About Sidharath Gupta

Sidharath’s passion for financial markets and love for words guided his way to become a financial writer. He began his career as an Equity Analyst researching stocks and preparing in-depth research reports. Sidharath is currently pursuing the CFA program to deepen his knowledge of financial analysis and investment strategies.

Sidharath’s daily coverage of the financial markets keeps him on top of key trends, with the goal of helping investors make well-informed decisions.


Recent Articles By Sidharath Gupta

: CRM |  News, Ratings, and Charts

Salesforce vs. HubSpot: Which CRM Stock is a Better Buy?

Software has been serving as a vital medium of business and communication as the COVID-19 pandemic has forced companies to digitize at an accelerated pace. A pandemic-ready, software-as-a-service business model helped Salesforce.com (CRM) and HubSpot (HUBS) deliver robust financial results last year. And with most organizations now permanently shifting their operations online, we believe these names should continue to grow on the back of their continued innovations. However, let’s find out which of these stocks is a better buy now.
: RKT |  News, Ratings, and Charts

4 Stocks with More Than 30% Short Interest

The stock market has been witnessing a short squeeze wave over the past few months, driven largely by millennial investors trying to crush Wall Street short sellers who are betting against struggling businesses. Rocket Cos. (RKT), GSX Techedu (GSX), Gogo Inc. (GOGO) and Clovis Oncology (CLVS) are four stocks that have witnessed a large short position over the past few months. This suggests potential trouble ahead for these stocks. However, if the market continues to move higher and short sellers are compelled to close out their positions, these stocks could skyrocket. Let’s learn what’s in store for these stocks.
: JNJ |  News, Ratings, and Charts

Johnson & Johnson vs. Moderna: Which Vaccine Stock is a Better Buy?

Johnson & Johnson (JNJ) and Moderna (MRNA) are two healthcare companies that have successfully developed COVID-19 vaccines which are currently being distributed throughout the U.S. Both companies’ stocks have seen impressive gains in the past year. Here we examine each company to determine which stock is a better buy in 2021.
: SQ |  News, Ratings, and Charts

Square: Buy, Sell, or Hold?

Fintech stocks have been trending up since the onset of the COVID-19 pandemic due to widespread adoption of remote financial transactions. However, the shares of hypergrowth fintech major Square (SQ) have been on a multi-week downtrend due to recent developments at the company, slowing digital payments, and anticipation of a broader tech-sector slowdown. Shares of SQ have declined nearly 12% over the past month. Read ahead to learn whether SQ is a good addition to your portfolio now.
: ASML |  News, Ratings, and Charts

ASML Holding vs. Qualcomm: Which Semiconductor Stock is a Better Buy?

The ongoing tech revolution—with its rapid growth in Artificial Intelligence (AI), 5G networks, Internet of Things (IoT), and autonomous driving—is increasing the demand for powerful, energy-efficient microchips and semiconductor equipment. With this, prominent players in this space, such as ASML Holding (ASML) and QUALCOMM Incorporated (QCOM), are set to benefit immensely from widespread digitization and society’s increasing dependence on smart devices. But which of these stocks is a better buy now? Let’s find out.
: GOOGL |  News, Ratings, and Charts

The One FAANG Stock That's Trading Up in 2021, and It's Rated Strong Buy

Among the technology juggernauts, the FAANG stocks did well last year as the pandemic triggered increased adoption of internet and e-commerce. However, Alphabet (GOOGL) is the only FAANG component that has gained so far this year, based on its dominance in the search space and continued innovations to meet changing consumer preferences. Read ahead to learn why GOOGL could be a good addition to your portfolio now.
: CARR |  News, Ratings, and Charts

Forget Palantir, Buy These 3 Recent IPO Stocks Instead

Despite a global economic slowdown caused by the COVID-pandemic last year, the capital markets have seen the highest level of capital raising activity through IPOs over the past decade. Indeed, recently listed analytical major Palantir Technologies (PLTR) garnered better-than-anticipated price gains in secondary market trading despite the company’s decades-long lack of profitability. This outcome is in-part why we believe Carrier Global Corp. (CARR), Otis Worldwide Corp. (OTIS) and Playtika Holding Corp. (PLTK) are three IPO stocks that are better positioned to deliver promising returns due to their compelling growth drivers. Read on for some details.
: GPI |  News, Ratings, and Charts

3 Small-Cap Value Stocks for an Improving Economy

Value investing strategies have been largely sidelined since the COVID-19 pandemic-driven market correction last March. Since then, a rocketing rally by growth stocks has commanded most investors’ attention. However, an expected economic recovery this year is shifting investors’ focus to quality bargains now. While most investors consider small-cap stocks highly risky investments, some small-cap stocks with strong fundamentals hold explosive return potential. Based on this, we believe Group 1 Automotive, Inc. (GPI), Nu Skin Enterprises, Inc. (NUS) and Owens & Minor, Inc. (OMI) are good value bets to play the economic recovery. Read on.
: SAIL |  News, Ratings, and Charts

SailPoint Technologies: Buy, Sell, or Hold?

With most businesses operating on cloud platforms amid the COVID-19 pandemic, organizations around the globe have been placing a higher emphasis on cybersecurity and identity management. SailPoint Technologies Holdings (SAIL) has risen to the occasion in protecting businesses from the risk that comes with providing electronic access to information across remote workforces. Consequently, its stock has more than doubled over the past year. Read ahead to learn whether SAIL is a good addition to one’s portfolio now.
: ALL |  News, Ratings, and Charts

Forget Lemonade, Buy This Insurance Stock Instead

The COVID-19 pandemic created opportunities for life insurance and home protection businesses. But while new-age insurance major Lemonade (LMND) has surged, driven by a red-hot IPO market, it has turned sour this year due to recent developments at the company. Conversely, Allstate Corporation (ALL) has been riding high on increased healthcare benefit costs and robust expansion strategies.
Page generated in 1.6671 seconds.